S. Martin Shreeve

10.0k total citations · 1 hit paper
52 papers, 1.7k citations indexed

About

S. Martin Shreeve is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Martin Shreeve has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Martin Shreeve's work include Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (8 papers) and Lung Cancer Treatments and Mutations (8 papers). S. Martin Shreeve is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (8 papers) and Lung Cancer Treatments and Mutations (8 papers). S. Martin Shreeve collaborates with scholars based in United States, United Kingdom and Australia. S. Martin Shreeve's co-authors include D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, John A. Bevan, Sai‐Hong Ignatius Ou, Gregory J. Riely, Keith D. Wilner, Daniel B. Costa, Robin Wiltshire and Lucio Crinò and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

S. Martin Shreeve

50 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases

2015 468 citations Daniel B. Costa, Alice T. Shaw et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Martin Shreeve United States	16	818	814	714	278	221	52	1.7k
Azucena Esparís‐Ogando Spain	27	1.3k 1.6×	861 1.1×	160 0.2×	262 0.9×	229 1.0×	45	2.0k
Setsuo Takai Japan	18	1.2k 1.5×	553 0.7×	199 0.3×	443 1.6×	97 0.4×	42	1.9k
Raymond R. Mattingly United States	30	1.4k 1.7×	648 0.8×	218 0.3×	414 1.5×	123 0.6×	70	2.3k
Gerald E. Stoica United States	9	771 0.9×	388 0.5×	204 0.3×	183 0.7×	109 0.5×	9	1.3k
Klaus Edvardsen Denmark	24	781 1.0×	419 0.5×	155 0.2×	282 1.0×	163 0.7×	40	1.6k
Dario Marchetti United States	20	689 0.8×	892 1.1×	285 0.4×	606 2.2×	85 0.4×	36	1.6k
Ruoqian Shen United States	18	593 0.7×	442 0.5×	551 0.8×	283 1.0×	47 0.2×	27	1.2k
José A. Galván Switzerland	22	672 0.8×	675 0.8×	274 0.4×	275 1.0×	58 0.3×	48	1.6k
Anders Eriksson Sweden	19	1.2k 1.5×	316 0.4×	186 0.3×	196 0.7×	258 1.2×	36	2.1k
Landon J. Inge United States	21	1.1k 1.3×	433 0.5×	242 0.3×	307 1.1×	50 0.2×	41	1.7k

Countries citing papers authored by S. Martin Shreeve

Since Specialization

Citations

This map shows the geographic impact of S. Martin Shreeve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Martin Shreeve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Martin Shreeve more than expected).

Fields of papers citing papers by S. Martin Shreeve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Martin Shreeve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Martin Shreeve. The network helps show where S. Martin Shreeve may publish in the future.

Co-authorship network of co-authors of S. Martin Shreeve

This figure shows the co-authorship network connecting the top 25 collaborators of S. Martin Shreeve. A scholar is included among the top collaborators of S. Martin Shreeve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Martin Shreeve. S. Martin Shreeve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, Peter, Sriram Balasubramanian, Brendan P. Hodkinson, et al.. (2023). Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial. Blood Advances. 7(10). 2008–2017. 21 indexed citations

Cho, Byoung Chul, Enriqueta Felip, Hidetoshi Hayashi, et al.. (2021). MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer. Future Oncology. 18(6). 639–647. 63 indexed citations

Jones, Suzanne F., Lillian L. Siu, Johanna C. Bendell, et al.. (2015). A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors. Investigational New Drugs. 33(5). 1100–1107. 125 indexed citations

Shaw, Alice T., Sai‐Hong Ignatius Ou, Yung‐Jue Bang, et al.. (2014). Clinical Activity of Crizotinib in Ros1-Rearranged Non-Small Cell Lung Cancer. Annals of Oncology. 25. iv458–iv458. 7 indexed citations

Lee, Brian Y., Falko Hochgräfe, Hui‐Ming Lin, et al.. (2013). Phosphoproteomic Profiling Identifies Focal Adhesion Kinase as a Mediator of Docetaxel Resistance in Castrate-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 13(1). 190–201. 41 indexed citations

Infante, Jeffrey R., D. Ross Camidge, Linda Mileshkin, et al.. (2012). Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors. Journal of Clinical Oncology. 30(13). 1527–1533. 195 indexed citations

Palmieri, Diane, Daniel P. Fitzgerald, S. Martin Shreeve, et al.. (2009). Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis. Molecular Cancer Research. 7(9). 1438–1445. 173 indexed citations

Horak, Christine E., Jong‐Heun Lee, Jean‐Claude Marshall, S. Martin Shreeve, & Patricia S. Steeg. (2008). The role of metastasis suppressor genes in metastatic dormancy. Apmis. 116(7-8). 586–601. 80 indexed citations

Shreeve, S. Martin, Miles P. Hacker, David Gannon, & John C. Kermode. (2006). Vasoactive Intestinal Peptide Activates both Gs and Gi in Lung. Annals of the New York Academy of Sciences. 805(1). 516–520.

10.

Shreeve, S. Martin. (2002). Identification of G-Proteins Coupling to the Vasoactive Intestinal Peptide Receptor VPAC1 Using Immunoaffinity Chromatography: Evidence for Precoupling. Biochemical and Biophysical Research Communications. 290(4). 1300–1307. 14 indexed citations

11.

Thorin, Éric, Marie A. Shatos, S. Martin Shreeve, Carrie L. Walters, & John A. Bevan. (1997). Human Vascular Endothelium Heterogeneity. Stroke. 28(2). 375–381. 57 indexed citations

12.

Diehl, Nicole L. & S. Martin Shreeve. (1994). Identification of the α1C-adrenoceptor in rabbit arteries and the human saphenous vein using the polymerase chain reaction. European Journal of Pharmacology Molecular Pharmacology. 268(3). 393–398. 8 indexed citations

13.

Shreeve, S. Martin, et al.. (1992). Molecular properties of the vasoactive intestinal peptide receptor in aorta and other tissues. Peptides. 13(5). 919–926. 12 indexed citations

14.

Shreeve, S. Martin, et al.. (1992). Reconstitution of α1-adrenoceptors having high affinity for prazosin. European Journal of Pharmacology Molecular Pharmacology. 226(3). 191–197. 3 indexed citations

15.

Shreeve, S. Martin, et al.. (1992). The α1-adrenoceptor is inactivated by alterations in membrane phospholipids. European Journal of Pharmacology Molecular Pharmacology. 226(1). 29–33. 10 indexed citations

16.

Shreeve, S. Martin. (1990). Effect of detergent solubilization on the affinity of some quinazoline derivatives for the α1-adrenoceptor. European Journal of Pharmacology Molecular Pharmacology. 188(1). 71–80. 3 indexed citations

17.

Shreeve, S. Martin. (1988). Classification of bovine aortic alpha-1 adrenoceptors by the criteria of ligand affinity and molecular mass.. Journal of Pharmacology and Experimental Therapeutics. 245(3). 1060–1067. 9 indexed citations

18.

Hemsworth, B A, et al.. (1984). 3‐Hydroxy‐N,N‐dimethylpiperidinium: a precursor of a false cholinergic transmitter. British Journal of Pharmacology. 82(2). 477–484. 3 indexed citations

19.

Hemsworth, B A, et al.. (1984). Pharmacological actions of some cyclic analogues of choline. British Journal of Pharmacology. 81(4). 685–692. 5 indexed citations

20.

Hemsworth, B A, et al.. (1979). 1,1-Dimethyl-3-acetoxypiperidine, a new cholinergic false transmitter [proceedings].. PubMed Central. 66(3). 465P–465P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact